Publikationen
Chambers and Partners – Switzerland: Patent Litigation 2025
Chambers and Partners - Switzerland: Patent Litigation, January 2025- EN
Swiss Federal Supreme Court confirms validity of Bristol-Myers Squibb’s SPC for apixaban
Bristol-Myers Squibb successfully defended the Swiss SPC for the pharmaceutical active ingredient apixaban, used in the blockbuster anticoagulant Eliquis.- EN
Legal 500: Patent Litigation Comparative Guide
The Legal 500 Country Comparative Guides 2024, October 2024- EN
Patent Litigation 2024 Switzerland – Trends and Developments
Chambers and Partners, Global Practice Guides, Patent Litigation 2024, February 15, 2024- EN
The Legal 500 Country Comparative Guides 2023 – Switzerland: Patent Litigation
The Legal 500 Country Comparative Guides 2023, November 2023- EN
Patent Litigation 2023 Switzerland – Trends and Developments
Chambers and Partners, Global Practice Guides, Patent Litigation 2023, 01 March 2023- EN
- Simon Holzer
- Ulrike Ciesla
- Louisa Galbraith
- Simon Reuter
The Legal 500 Country Comparative Guides 2022 – Switzerland: Patent Litigation
The Legal 500 Country Comparative Guides 2022, November 2022- EN
Patent Litigation 2022 Switzerland – Trends and Developments
Chambers and Partners, Global Practice Guides, Patent Litigation 2022, 15 February 2022- EN
Little-known pitfall in application for paediatric extensions or paediatric SPCs
International Law Office (ILO), 14 February 2022- EN
The Legal 500 Country Comparative Guides 2021 – Switzerland: Patent Litigation
The Legal 500 Country Comparative Guides 2021, November 2021- EN
Question of fact or law – court sheds light on longstanding issue in Swiss patent law, or does it?
International Law Office (ILO), 27 September 2021- EN
Limitation of patents during infringement proceedings – case law and strategic considerations
International Law Office, 22 March 2021- EN
